Archive for Stock Market News

Coronovirus epidemic scare weighs on global markets

By IFCMarkets

Dollar strengthening intact

US stock market retreat accelerated on Monday as global community pondered about possible impact of coronavirus infection in China with issues like true effectiveness of quarantines and infectiousness degree of the coronavirus adding to sense of uncertainty. The S&P 500 lost 1.6% to 3243.63. Dow Jones industrial fell 1.6% to 28535.8. The Nasdaq dropped 1.9% to 9088.04. The dollar strengthening slowed ahead of Fed’s two day meeting starting today as sales of newly constructed homes in the US unexpectedly dropped 0.4% on month in December: the live dollar index data show the ICE US Dollar index, a measure of the dollar’s strength against a basket of six rival currencies, added 0.1% to 97.93 and is lower currently. Fourth quarter earnings season continues with Apple, Visa, Phizer and AMD slated to report results today. Futures on stock indexes point to higher openings today.

DAX 30 led European indexes retreat

European stocks pulled back on Monday as coronavirus outbreak scare undermined investors’ confidence. The slide of EUR/USD and GBP/USD continued yesterday with both pairs lower currently. The Stoxx Europe 600 index lost 2.3% led by basic resources shares. The DAX 30 fell 2.7% to 13204.77 as Ifo institute reported German business sentiment deteriorated in January. France’s CAC 40 lost 2.68% while UK’s FTSE 100 slumped 2.3% to 7412.05.

Australia’s All Ordinaries Index leads Asian indexes retreat

Asian stock indices are in free fall today with markets in Hong Kong and mainland China closed for Lunar New Year holidays. Nikkei retreated 0.6% to 23215.71 despite accelerated yen slide against the dollar. Australia’s All Ordinaries Index lost 1.4% after reopening despite continued Australian dollar slide against the greenback.

AU200 dipping to MA(50) 1/28/2020 Market Overview IFC Markets chart

Saudi Aramco slips while Brent recovers

Brent futures prices are recovering today. Prices ended sharply lower yesterday: March Brent crude closed 2.3% lower at $59.32 a barrel on Monday. Saudi Aramco ‘s shares continue trading on the country’s Tadawul exchange. Shares are currently down 0.3% at 34.15 riyals.

Gold retraces lower after spike in heaven demand

Gold prices are edging lower today. February gold gained 0.4% ending at more than six-year high 1559.96 an ounce on Monday.

Market Analysis provided by IFCMarkets

Note:
This overview has an informative and tutorial character and is published for free. All the data, included in the overview, are received from public sources, recognized as more or less reliable. Moreover, there is no guarantee that the indicated information is full and precise. Overviews are not updated. The whole information in each overview, including opinion, indicators, charts and anything else, is provided only for familiarization purposes and is not financial advice or а recommendation. The whole text and its any part, as well as the charts cannot be considered as an offer to make a deal with any asset. IFC Markets and its employees under any circumstances are not liable for any action taken by someone else during or after reading the overview.

eHealth Shares Rise 25% After Achieving 100% Increase in Quarterly Medicare Advantage Sales

By The Life Science Report

Source: Streetwise Reports   01/24/2020

Online medical exchange operator eHealth Inc.’s shares traded higher after the firm reported preliminary financial results for Q4/19 and FY/19. The company advised that both quarterly and annual revenues exceeded prior estimates.

Private online health insurance exchange operator eHealth Inc. (EHTH:NASDAQ) yesterday announced preliminary, unaudited financial results and select operating metrics for the fourth quarter and fiscal year ended December 31, 2019. The firm advised that the preliminary financial results and selected operating metrics are based upon management’s initial review of operations in Q4/19 and FY/19 according to the best available data as of January 23, 2020.

The company reported that for Q4/19 it expects revenue to be in the range of $257.5-259.5 million including Medicare segment revenue in the range of $239-240.5 million. In the same corresponding period, the firm expects GAAP net income in the range of $53-$55 million and adjusted EBITDA to be in the range of $98.5-100.5 million.

The firm indicated that for FY/19 it expects revenue to be in the range of $462-464 million compared to previous guidance of $365-385 million including Medicare segment revenue expected in the range of $403.5-405 million compared to prior guidance of $318-333 million. For the full-year, the firm expects GAAP net income to be in the range of $31-33 million, compared to the company’s guidance of $20.9-25.9 million and adjusted EBITDA for FY/19 is expected to be in the range of $89-$91 million, compared to the company’s guidance of $65-70 million.

The firm indicated that the number of approved members for all Medicare products grew 88% during Q4/19 when compared to Q4/18. The company highlighted that its Medicare Advantage products grew 100% over the same time period. The company added that for full-year 2019, the number of approved members for all Medicare products grew 81% compared 2018 with approved members for Medicare Advantage products growing 88% over the same time period.

The company’s CEO Scott Flanders commented, “I am proud of our achievements in 2019. After raising our guidance twice in the past year, we significantly exceeded our financial and operating targets driven by consistently strong execution throughout the year. 2019 culminated with an exceptional performance by our team during the fourth quarter Medicare annual enrollment period. Our marketing and business development organizations drove record consumer demand to the eHealth platform allowing us to grow fourth quarter approved Medicare members in excess of 85%…We remain excited about the Medicare market opportunity and significant growth potential ahead of us and are looking forward to sharing our outlook for 2020 as part of our fourth quarter earnings release next month.”

The company describes its business as a leading private online health insurance exchange where individuals, families and small businesses can compare health insurance products from brand-name insurers side by side and purchase and enroll in coverage online or by phone. eHealth (www.ehealthinsurance.com) is licensed to sell health insurance through its subsidiaries in all 50 states and the District of Columbia. Additionally, the firm offers educational resources, telephone support, and online and pharmacy-based tools to help Medicare beneficiaries navigate Medicare health insurance options, choose the right plan and enroll in select plans online or over the phone through Medicare.com (www.Medicare.com), eHealthMedicare.com (www.eHealthMedicare.com), GoMedigap (www.goMedigap.com) and PlanPrescriber.com (www.PlanPrescriber.com).

eHealth started the day with a market capitalization of around $2.2 billion with approximately 23.1 million shares outstanding and a short interest of about 16.7%. EHTH shares opened nearly 19% higher today at $115.44 (+$18.31, +18.85%) compared to yesterday’s closing price of $97.13 and established a new 52-week intraday high price today of $130.00. The stock has traded today between $110.92 and $130.00 per share and is currently trading at $122.55 (+$25.41, +26.16%).

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Disclosure:
1) Stephen Hytha compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. He or members of his household own securities of the following companies mentioned in the article: None. He or members of his household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases.
6) This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.

( Companies Mentioned: EHTH:NASDAQ,
)

The Black Swan Event Begins

By TheTechnicalTraders.com

As the Asian markets opened on late Sunday, traders expected a reactionary price move related to the threat of the Wuhan virus and the continued news of its spread.  The US Dow Jones futures markets opened close to -225 points lower on Sunday afternoon and were nearly -300 points lower within the first 25 minutes of trading.  Gold opened $10 higher and continued to rally to a level above $15 higher.

If this is early price activity, or a reactionary price move, related to fear of what may come, then the warnings signs are very clear that global traders and investors believe this virus outbreak may very well turn into a major Black Swan event.

Our research team believes a 5% to 8% rotation should be considered a normal reversion range where price may find immediate support and attempt to rally from these support levels.  Anything beyond 10% may set up a much bigger price reversion event, something akin to a Black Swan event.  Therefore, we are advising our friends and followers to take the necessary steps to protect your wealth and assets as this move continued to extend.

30-Minute YM Futures Chart

This 30-minute YM futures chart highlights the reactionary downside price move (GAP) taking place on the open of the Asian markets.  This GAP lower may be just the beginning of a much broader downside price move.  We are going to have to wait and see what happens related to the Wuhan virus over the next 14+ days.

30-Minute Gold Futures Chart

Gold shot up nearly 1% in early trading on Sunday.  Fear is driving investors to pile into the precious metals markets.  As news of this virus continues to hit the news cycle, we expect metals will continue to push higher and higher – likely targeting the $1750 level in Gold.

If you want to see what the big money players own check out these gold charts and a very different interpretation of the gold COT Data here.

If you have not been following our research and if you have not already positioned your portfolio for this potential reversion event, then now would be a good time to start taking action.  Do some research on the 1855 Third Plague Event in China where more than 15 million people died (nearly 1.25% of the total global population at the time).  If those levels hold for this event, then possibly 60 to 80 million people may die over related to this event.

Oil is collapsing again and just his out downside target of $53. Our energy sector trade idea is up over 15% already.

Remember, all of this is speculation at this point.  Yet we urge traders to act now to take action to prevent further erosion of their wealth and retirement accounts.  Visit Technical Traders Ltd. to learn how we can help you plan for these events, protect your wealth, and find great trades.

As a technical analysis and trader since 1997 I have been through a few bull/bear market cycles, I have a good pulse on the market and timing key turning points for both short-term swing trading and long-term investment capital. The opportunities are massive/life-changing if handled properly.

Join my Wealth Building Newsletter if you like what you read here and ride my coattails as I navigate these financial markets and build wealth while others lose nearly everything they own.

Chris Vermeulen
TheTechnicalTraders.com

NOTICE: Our free research does not constitute a trade recommendation or solicitation for our readers to take any action regarding this research.  It is provided for educational purposes only.  Our research team produces these research articles to share information with our followers/readers in an effort to try to keep you well informed.  Visit our web site to learn how to take advantage of our members-only research and trading signals.

 

 

Coronavirus: investors should avoid knee-jerk reactions

By George Prior

Coronavirus is the number one threat to financial markets currently – but most investors should avoid knee-jerk reactions, affirms the CEO of one of the world’s largest independent financial advisory organizations.

Nigel Green, deVere Group chief executive and founder, is speaking out as global stock markets are rattled on fears of the potentially deadly Sars-like virus triggering major sell-offs.

The death toll has now risen to 81 and almost 3,000 people have been confirmed as infected, with 44 cases having been detected outside China, where it originated.

On Monday, the composite European Stoxx 600 fell 1.7% at the open, London’s FTSE 100 dropped 1.6%, while Germany’s Dax was 1.7% lower.  The slump followed a similarly dramatic decline in Asia overnight. The Shanghai Composite fell 2.7%, the Hong Kong Hang Seng lost 1.1%, and Japan’s Nikkei dropped 2%.

Mr Green says: “The Coronavirus is the number one threat to financial markets currently as global investors are becoming jittery on the uncertainty.

“But whilst this health crisis will inevitably hit some sectors, such as travel and retail, most investors who have a properly diversified portfolio should avoid knee-jerk reactions.  History teaches us that most issues of this kind have a short-term impact on stock markets.”

He continues: “Most investors should monitor the situation with their financial adviser and sit tight at present. But if it is still escalating next week, with much higher casualty rates, a more defensive approach might be necessary.

“However, the cost and effort of making such a switch means you do not do it lightly, and more evidence is needed that the virus does pose a medium to long term risk to China and the global economy.”

Mr Green goes on to say: “But that said, this should serve as a wake-up call to all investors to ensure their portfolio is well-diversified across asset classes, regions, sectors, even currencies.

“This is the best way to mitigate risks and the best way to be well-placed to take advantage of the opportunities when they occur.”

The deVere CEO concludes: “Stock markets tend to bottom with the peak in new cases during a public health issue of this kind, before rebounding.

“This is a worrying and serious situation and investors must be vigilant. They should remain properly diversified and remain in the market.”

About:

deVere Group is one of the world’s largest independent advisors of specialist global financial solutions to international, local mass affluent, and high-net-worth clients.  It has a network of more than 70 offices across the world, over 80,000 clients and $12bn under advisement

 

How Big Data And Analytics Is Transforming Manufacturing

When new technologies become cheaper and easier to use, they revolutionize industries. That’s what’s happening with Big Data right now.

Big Data analysts investigate large volumes of data to find hidden patterns, correlations, and other findings. Today’s technology allows you to analyze and respond to data almost instantly, which is can be slower and less efficient when using more traditional business analysis solutions.

Data plays a huge role in today’s production processes. Advances in robotics and increased levels of automation are fundamentally changing the face of production.

Today’s leaders in manufacturing are visionaries who are adopting more and more efficient methods of producing and moving physical goods while thinking not only about productivity but also about reducing costs and risks.

The future of survival will require manufacturers to be flexible, AI-centric organizations that minimize risk and seize opportunities through a deep understanding of operations and confident decision making.

Manufacturing analytics solutions enable them to set up production operations with minimal cost and risk while using data as an asset that helps deliver innovative services and quality products, which only possible in an interconnected economy.

Let’s look at the key ways big data and analytics are empowering and transforming manufacturers in 2020.

Photo by Annie Spratt

1. Increasing Data Accessibility, Availability, And Agility

One of the most significant advantages of using the analytical approach is the simplification of data.

Traditional production data sets are very complex and often require specialists with system knowledge and experience to obtain information from them. The vast amount of information generated by production processes every second also makes it virtually impossible to make accurate, timely, data-driven decisions without the use of business analytic models.

The first step to any analytical process is to collect data. Manufacturers are investing heavily in collecting data from internal sources, including production data collection systems (EMI) and production execution systems (MES).

Data is also collected from sensors, supervisory control and data acquisition systems (SCADA), human-machine interface software (HMI), and supply chain and enterprise resource planning applications.

After collecting and aggregating the data, various analytical methods are used to obtain information.

Analytical methods include predictive modeling, machine learning, simulation, optimization and process management, and business analytics tools.

However, performing analytics with comprehensive technology can be time-consuming and costly.

Various analytical methods are used to obtain information about the production:

  1. Using data visualization, determine initial patterns (using moving averages, distribution histograms, standard deviations, and clustering) to prioritize data collection and analysis.
  2. Using correlation analysis, identify the main determinants of process performance and formulate an initial hypothesis about the root causes of the decline and yield variability.
  3. Using significance testing, test the underlying hypothesis for root causes of yield decline and variability and focus on the most statistically significant factors for further research.
  4. Using artificial neural networks, simulate complex processes to quantify the impact and optimal ranges for the identified parameters.

These methods of analyzing large amounts of data reduce costs and help to avoid bottlenecks and identify KPIs to improve performance.

In a broad sense, some of the key functions of the analytics include:

  • Production improvement (operational efficiency)
  • A better understanding of plant performance and live warnings
  • Corresponding capacity in several plants
  • Perform predictive modeling based on production data
  • Interaction with suppliers
  • Understanding of customer needs
  • Better and faster service/customer support

2. Boosting Collaboration Opportunities Across The Board

Business analytics enables simultaneous access to different data sets for all stakeholders – from senior management to process owners, plant managers, and assembly line operators – on multiple devices or screens.

This increased sharing of information across the organization results in a closer collaboration that can ultimately improve product quality as well as minimize production costs and time.

For example, an operator on the floor can share data with a maintenance team to understand if the recent slowdown in production was caused by a technical failure on the assembly line. This allows the organization to identify and solve operational problems before they result in significant losses.

Another example is when Mercedes-Benz initially introduced an analytics system for the after-sales environment, they noticed the direct impact of this solution on operational optimization. Reporting became faster and more accurate as data processing time was significantly reduced while understanding the context allowed for more informed decisions.

This later led to the introduction of software for other functions such as production, sales, and human resources management. With a single data architecture that controls all business analytics, improved access to information thus simplified the entire organization and led to an increased inter-departmental collaboration of data.

3. Optimizing Business Functions And Driving Efficiency

No matter how efficient automated data analytics is, algorithms are often developed to find a concrete result. This often makes it difficult for manufacturers to get a holistic view of their complex data sets.

Business analytics, on the other hand, allows multiple stakeholders to interact with data sets live and conveniently. This allows for the integration of operational and experimental data for detailed information, which in turn can help optimize processes and improve the efficiency of production.

Besides, inbound and outbound supply chains can be strengthened, as well as resource discovery and utilization can be optimized to meet current and future demand.

Business data can also help identify additional sources of revenue and business growth opportunities for manufacturers more accurately.

Supply chain visibility is one of the critical challenges faced by manufacturers. This is partly due to large volumes of data such as product manufacturing, packaging, delivery/logistics, coding, etc. – involved in supply chain management.

Business analytics brings this information to the forefront, allowing manufacturers to identify and address supply chain bottlenecks. It helps improve supply chain responsiveness, reduce risk, and lower production costs.

4. Enabling swifter and more accurate decision-making

By providing a holistic view of all data across the business ecosystem, including from multiple sources, business intelligence allows manufacturers to delve deeper into their data and identify different trends and patterns relevant to them.

This review style approach allows them to analyze data using specific models and make accurate, proactive decisions.

Users can also take into account different data points, historical precedents, anomalies, measures taken, and their degree of effectiveness, acceptability of results, etc. to make more accurate decisions.

This helps them not only in their decision-making process but also in understanding why they are making particular decisions.

5. Making Factories “Smarter” And Benefiting From IoT

Industrie 4.0 is a perfect example of what modern factories will look like. It is an initiation of the German government – a high-tech strategy to promote computerization of production, which laid the foundation for smart factories. It covers every process from product idea to development and from recycling to maintenance.

Industrie 4.0 includes:

  • Interoperability: Machines and sensors connected to the network and working synchronously.
  • Automation: Physical devices are able to make their own decisions and are therefore automated.

While experts believe that India is one of the most ideal countries to benefit from, the Industrie 4.0 model, Cincinnati, Ohio, has already declared itself an “Industry 4.0 Demonstration City.” They are also investing heavily in innovation and development to address any major industry challenges they may face.

Since IoT is gaining fame in the industry, the future analytics will be a mixture of IoT and big data analytics implementation.

IIoT collects data from sensors, their transmissions, and microcontrollers that can track information and help manage the data. These two components together transform production processes and management, making manufacturers smart.

However, combining these two technologies requires new infrastructure, including hardware and software, as well as an operating system. Manufacturers will have to deal with the large inflow of data that begins to arrive and analyze it live as it grows over time.

6. Optimizing Quality Checks

Intel is one of the largest companies that actively integrates BDA into its production processes. Since quality assurance is an integral part of the chip production process, as with most manufacturers, they have to perform about 19,000 tests on each chip.

However, using the power of BDA, it has been able to reduce these steps significantly. For example, Intel’s analytics system can now view historical data collected during the manufacturing process at the plate level and identify only those chips that need to be tested.

In 2012, the chipmaker saved about $3 million in manufacturing costs using the predictive analysis process implemented on the Intel Core line of processors.

7. Improving Accuracy and Quantity of Production

McKinsey gave an excellent example of how BDA can significantly improve production practices. A biopharmaceutical manufacturer that manufactures a specific category of pharmaceutical products that includes blood components, hormones, and vaccines need to monitor more than 200 variables to ensure their purity.

Surprisingly, the yield of two separate batches of the same product produced using the same process can vary from 50% to 100%. Given how expensive medical products can be, even a 10% yield difference can be costly. Fortunately, there is a simple solution.

By dividing the entire production process into smaller segments and applying data analysis to each of them, the project team can process the dependencies between them and the parameters directly responsible for the yield difference.

Therefore, by adjusting these parameters accordingly, the team can quickly increase production by as much as 50%, saving up to $10 million per year.

8. Bettering Collaboration to Promote 3D Printer Factories and MaaS

3D printers are a trend, much like BDA. The factory that manufactures 3D printers can work easily and, more effectively, on the bases of BDA.

Moreover, we can offer a new type of service – Manufacture as a service (MaaS), the same as software as a service (Software-as-a-Service), which we have today.

Manufacturers of 3D printers, such as Materialise and Shapeways, already work on MaaS.

Making about 200 000 products a month, lastly, do tremendous business utilizing the automated software and 3D-printers, which work 24 hours a day, seven days a week.

Using BDA, these factories can work in the environment with a high level of cooperation where the stream of data and information passing through engineering, operators of machine tools, quality assurance, etc., is seamless. The result is amazing efficiency and fast feedback.

To Sum Up: Is BDA the future of the manufacturing industry?

In conclusion, BDA provides us with the tools and technologies to help create a world in which automated factories produce products with maximum efficiency and cause minimal wasting of time and resources. Besides, the leading players are already aware of this and have, therefore, taken the initiative.

Of the more than 200 North American manufacturing executives that were interviewed, nearly 68% outlined their plans to invest in data analytics to become more competitive in their highly competitive business environment. This indicates that data is rapidly growing into the new gold standard in manufacturing.

Nevertheless, much smaller volumes of data have begun to provide valuable information and real business value based on available data. Developing a strategy for a particular company and implementing a carefully planned initiative in this area is a complex task that requires considerable time and effort.

Author’s bio: 

Dmitrii B. is the founder of GRIN tech – full-service agency.

 

DAX bulls hold 13,400 points – new all-time highs coming?

By Admiral Markets

Source: Economic Events January 24, 2020 – Admiral Markets’ Forex Calendar

Last Wednesday, the DAX30 CFD finally made it to new all-time highs, but the question for the coming days is now whether bulls can gain further bullish momentum.

The strong weekly close after the important support around 13,380/400 points was successfully defended against the bulls last Thursday, and is a positive sign which brings the last weekly highs (and current all-time highs) of around 13,640 points into our focus for the start of the new week of trading.

A break higher activates targets on the upside around 13,800 and 14,000 points in the upcoming days, as long as we trade above 13,380/400 points.

From a seasonal perspective, we favour the long side, too: with the Fed rate decision on Wednesday, we’d like to point out several studies which show that since the 1980’s, the days before the Fed rate decision and especially the 24 hours before the event, US Equities, but also the German DAX30, showed on average a positive performance when trading the Long side.

Still, if we, on the other hand, fail to break sustainably higher, get to see another test of the region around 13,380/400 points and a break lower, a test of the region around 13,250/270 points seems likely.

Source: Admiral Markets MT5 with MT5-SE Add-on DAX30 CFD Hourly chart (between January 7, 2019, to January 24, 2020). Accessed: January 24, 2020, at 10:00 PM GMT

Source: Admiral Markets MT5 with MT5-SE Add-on DAX30 CFD Daily chart (between October 12, 2018, to January 24, 2020). Accessed: January 24, 2020, at 10:00pm GMT – Please note: Past performance is not a reliable indicator of future results, or future performance.

In 2015, the value of the DAX30 CFD increased by 9.56%, in 2016, it increased by 6.87%, in 2017, it increased by 12.51%, in 2018, it fell by 18.26%, in 2019, it increased by 26.44% meaning that after five years, it was up by 34.2%.

Discover the world’s #1 multi-asset platform

Admiral Markets offers professional traders the ability to trade with a custom, upgraded version of MetaTrader 5, allowing you to experience trading at a significantly higher, more rewarding level. Experience benefits such as the addition of the Market Heat Map, so you can compare various currency pairs to see which ones might be lucrative investments, access real-time trading data, and so much more. Click the banner below to start your FREE download of MT5 Supreme Edition!

Download MetaTrader 5 and begin trading today!

Disclaimer: The given data provides additional information regarding all analysis, estimates, prognosis, forecasts or other similar assessments or information (hereinafter “Analysis”) published on the website of Admiral Markets. Before making any investment decisions please pay close attention to the following:

  1. This is a marketing communication. The analysis is published for informative purposes only and are in no way to be construed as investment advice or recommendation. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and that it is not subject to any prohibition on dealing ahead of the dissemination of investment research.
  2. Any investment decision is made by each client alone whereas Admiral Markets shall not be responsible for any loss or damage arising from any such decision, whether or not based on the Analysis.
  3. Each of the Analysis is prepared by an independent analyst (Jens Klatt, Professional Trader and Analyst, hereinafter “Author”) based on the Author’s personal estimations.
  4. To ensure that the interests of the clients would be protected and objectivity of the Analysis would not be damaged Admiral Markets has established relevant internal procedures for prevention and management of conflicts of interest.
  5. Whilst every reasonable effort is taken to ensure that all sources of the Analysis are reliable and that all information is presented, as much as possible, in an understandable, timely, precise and complete manner, Admiral Markets does not guarantee the accuracy or completeness of any information contained within the Analysis. The presented figures refer that refer to any past performance is not a reliable indicator of future results.
  6. The contents of the Analysis should not be construed as an express or implied promise, guarantee or implication by Admiral Markets that the client shall profit from the strategies therein or that losses in connection therewith may or shall be limited.
  7. Any kind of previous or modeled performance of financial instruments indicated within the Publication should not be construed as an express or implied promise, guarantee or implication by Admiral Markets for any future performance. The value of the financial instrument may both increase and decrease and the preservation of the asset value is not guaranteed.
  8. The projections included in the Analysis may be subject to additional fees, taxes or other charges, depending on the subject of the Publication. The price list applicable to the services provided by Admiral Markets is publicly available from the website of Admiral Markets.
  9. Leveraged products (including contracts for difference) are speculative in nature and may result in losses or profit. Before you start trading, you should make sure that you understand all the risks.

By Admiral Markets

Stocks skid after coronavirus infection spread in China

By IFCMarkets

Dollar strengthening halts

US stock market ended the week on down notes on Friday as the respiratory virus spread in China. The S&P 500 fell 0.9% to 3295.47, retreating 1.0% for the week. Dow Jones industrial slid 0.6% to 28989.73. The Nasdaq lost 0.9% to 9314.91. The dollar strengthening continued as Markit’s composite PMI reached a 10-month high reading for January. The live dollar index data show the ICE US Dollar index, a measure of the dollar’s strength against a basket of six rival currencies, rose 0.2% to 97.86 but is lower currently. Futures on stock indexes point to lower openings today.

European stock indexes rebounded

European stocks rebounded on Friday supported by positive data. Both GBP/USD and EUR/USD continued thier slide on Friday with euro turning higher currently and Pound lower still. The Stoxx Europe 600 Index recovered 9%. The DAX 30 gained 1.4% Friday to 13576.68 as both manufacturing and services PMIs beat expectations for January. France’s CAC 40 rose 0.9% and UK’s FTSE 100 advanced 1% to 7585.98 as the composite PMI returned to growth after recording a contraction for December.

EU50 testing MA(50) 1/27/2020 Market Overview IFC Markets chart

Nikkei falls as China extends New Year holidays

Asian stock indices are down today with markets in China, Hong Kong, Australia and South Korea closed for holidays. Nikkei fell 2% to 23343.51 despite resumed yen slide against the dollar. China’s markets are closed while the end of New Year holidays were extended to Sunday from Thursday.

Saudi Aramco slips while Brent slumps

Brent futures prices are extending losses today. Prices fell on Friday as oil-field services firm Baker Hughes reported the number of US oil rigs rose by three this week to 676: Brent for March settlement fell 2.2% to $60.69 a barrel Friday. Saudi Aramco shares are down currently 0.4% to 34.15 riyals as they continue trading on country’s Tadawul exchange. Brand Finance’s annual global study ranked it the most valuable brand in the Middle East and North Africa, with a brand value of $46.8bn. Aramco was ranked 24th globally, and the second most valuable oil and gas brand, within striking distance of Shell.

Gold extends gains

Gold prices are extending gains after rising Friday. February gold gained 0.4% to 1571.30 on Friday.

Market Analysis provided by IFCMarkets

Note:
This overview has an informative and tutorial character and is published for free. All the data, included in the overview, are received from public sources, recognized as more or less reliable. Moreover, there is no guarantee that the indicated information is full and precise. Overviews are not updated. The whole information in each overview, including opinion, indicators, charts and anything else, is provided only for familiarization purposes and is not financial advice or а recommendation. The whole text and its any part, as well as the charts cannot be considered as an offer to make a deal with any asset. IFC Markets and its employees under any circumstances are not liable for any action taken by someone else during or after reading the overview.

Co-Diagnostics Utilizes CoPrimer Platform to Design New Coronavirus Detection Test

By The Life Science Report

Source: Streetwise Reports   01/23/2020

Molecular diagnostics company Co-Diagnostics’ shares opened more than 144% higher after the firm reported it has designed a test for virus detection of the new coronavirus, 2019-nCoV, using its CoPrimer™ platform.

In the wake of widespread news and worldwide concerns regarding efforts to contain the spread of the latest strain of the coronavirus, Salt Lake City, Utah-based molecular diagnostics company Co-Diagnostics Inc. (CODX:NASDAQ), today announced that “it has completed principle design work for a PCR screening test for new coronavirus, 2019-nCoV, intended to address potential need for detection of the virus.”

The company indicated that following the guidelines published by the World Health Organization (WHO) and Centers for Disease Control (CDC), the new test was designed using its proprietary software system featuring the firm’s patented CoPrimer™ technology.

The firm advised that “an outbreak of respiratory illness caused by the pneumonia-like 2019-nCoV has spread rapidly over the past two weeks, after first being discovered in the Chinese city of Wuhan on December 31, 2019.” Subsequently, Chinese officials confirmed human-to-human transmission of the virus on January 20, 2020, and have implemented a soft quarantine effectively placed on Wuhan, warning people not to travel to or from the city. Wuhan has a population of approximately 11 million and is located along the Yangtze River about 500 miles due west of Shanghai.

The company’s CEO Dwight Egan commented, “There are several challenges to developing a test for a virus so relatively new on the world stage, especially one with many closely related genetic cousins such as SARS and MERS. One of the most important advantages of our CoPrimer platform is its ability to reliably and accurately differentiate between similar genetic sequences, in order to reduce the likelihood of a false positive diagnosis. With a situation currently unfolding where at least 17 deaths have already been reported among the hundreds infected, it is vital that healthcare professionals have access to the highest-quality diagnostic tools available, to be able to provide prompt and accurate diagnoses…We believe that if the WHO takes the step of declaring the illness a global health emergency following collection of more data in the days and weeks to come, Co-Diagnostics will be well positioned to quickly assist in providing these state of the art tools to affected countries.”

Co-Diagnostics is a molecular diagnostics firm headquartered in Salt Lake City, Utah, that “develops, manufactures and markets new, state-of-the-art diagnostics technology”. The company employs its innovative molecular tools for detection of infectious diseases, liquid biopsies for cancer screening and agricultural applications. The firm’s technology is “utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA).” In addition, Co-Diagnostics creates and licenses specific tests in order to locate genetic markers for use in other applications and industries besides infectious diseases.

Co-Diagnostics started the day with a market capitalization of around $19.6 million with approximately 17.34 million shares outstanding and a short interest of about 3.4%. CODX shares opened greater than 140% higher today at $2.76 (+$1.63, +144.25%) over yesterday’s $1.13 closing price. The stock has traded today between $1.88 and $2.80 per share and is currently trading at $2.20 (+$1.07, +94.69%).

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Disclosure:
1) Stephen Hytha compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. He or members of his household own securities of the following companies mentioned in the article: None. He or members of his household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases.
6) This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.

( Companies Mentioned: CODX:NASDAQ,
)

Premier Health Group Update: Charting ‘Strongly Bullish’ Movement

By The Life Science Report – Source: Clive Maund for Streetwise Reports   01/24/2020

Technical analyst Clive Maund examines this potential of the company’s stock.

The timing was off when we bought this stock back in the fall, as after we bought the price slumped back toward the lows again. What happened was that I had interpreted the pattern forming as a completing cup-and-handle base, but then it morphed into a double bottom. We can see what happened on the two-year chart, and how the pattern still has some attributes of a cup-and-handle base, so that it may be described as a hybrid pattern between that and a double bottom. As it now more closely resembles the latter, that is what we will label it as.

clive2yr

The most striking point to notice on these charts is that, while the Premier Health Group Inc. (PHGI:CSE; PHGRF:OTCQB; 6PH:FSE) stock price has risen significantly from its December lows—so that we have more than made good our loss—the advance has been driven by persistent strong volume that has caused a spectacular ramp-up in the accumulation line, and has also taken the on-balance volume line to new highs. This is an indication that almost all of the volume is upside volume, which is strongly bullish. This also normally implies that a stock is building up to a big move, which means that it should have little trouble overcoming the resistance that has temporarily capped the advance.

Thus, it is interesting to observe the current bunching of the price and its moving averages, which means that any further advance from here will quickly lead to a moving average cross and the 200-day turning up, a development that typically marks the start of a major bull market.

On the nine-month chart we can see recent action in more detail, and how the sharp advance from the middle of December has brought the price up to resistance at the September highs, where it has stalled out, as we would expect. However, the extraordinarily strong volume indicators, especially the accumulation line, imply that it will soon turn higher and storm through this resistance.

Thus it is also interesting to observe that when it tried to drop back further yesterday in the early trade, buyers snapped at it from beneath, driving the price back up to leave a bull hammer on the chart by the close. This action could well mark the end of a tiny correction that will be soon followed by a breakout above the resistance. The next stop on its way up will be the resistance approaching the $0.70 area.

clive9mo

We therefore stay long, and the stock is rated a buy here, and especially on any minor near-term dips.

Premier Health Group website
Premier Health Group Inc. closed at CA$0.49 ($0.32) on 23rd January 20.

Article originally posted at 9:25 a.m. EST on CliveMaund.com on 24th January 2020.

Clive Maund has been president of www.clivemaund.com, a successful resource sector website, since its inception in 2003. He has 30 years’ experience in technical analysis and has worked for banks, commodity brokers and stockbrokers in the City of London. He holds a Diploma in Technical Analysis from the UK Society of Technical Analysts.

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Disclosure:
1) Clive Maund: I, or members of my immediate household or family, own shares of the following companies mentioned in this article: None. I personally am, or members of my immediate household or family are, paid by the following companies mentioned in this article: None. My company has a financial relationship with the following companies mentioned in this article: None. CliveMaund.com disclosures below. I determined which companies would be included in this article based on my research and understanding of the sector.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Statements and opinions expressed are the opinions of the author and not of Streetwise Reports or its officers. The author is wholly responsible for the validity of the statements. The author was not paid by Streetwise Reports for this article. Streetwise Reports was not paid by the author to publish or syndicate this article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
4) This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Premier Health, a company mentioned in this article.

Charts provided by the author.

CliveMaund.com Disclosure:
The above represents the opinion and analysis of Mr Maund, based on data available to him, at the time of writing. Mr. Maund’s opinions are his own, and are not a recommendation or an offer to buy or sell securities. Mr. Maund is an independent analyst who receives no compensation of any kind from any groups, individuals or corporations mentioned in his reports. As trading and investing in any financial markets may involve serious risk of loss, Mr. Maund recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction and do your own due diligence and research when making any kind of a transaction with financial ramifications. Although a qualified and experienced stock market analyst, Clive Maund is not a Registered Securities Advisor. Therefore Mr. Maund’s opinions on the market and stocks can only be construed as a solicitation to buy and sell securities when they are subject to the prior approval and endorsement of a Registered Securities Advisor operating in accordance with the appropriate regulations in your area of jurisdiction.

( Companies Mentioned: PHGI:CSE; PHGRF:OTCQB; 6PH:FSE,
)

The Wuhan Wipeout – Could It Happen?

By TheTechnicalTraders.com

News is traveling fast about the Corona Virus that originated in Wuhan, China.  Two new confirmed cases in the US, one in Europe and hundreds in China.  As we learn more about this potential pandemic outbreak, we are learning that China did very little to contain this problem from the start.  Now, quarantining two cities and trying to control the potential outbreak, may become a futile effort.

In most of Asia, the Chinese New Year is already in full swing.  Hong Kong, China, Singapore, Malaysia, India and a host of other countries are already starting to celebrate the 7 to 10 day long New Year.  Millions of people have already traveled hundreds of thousands of miles to visit family throughout this massive celebration.  We are certain that hundreds or thousands have traveled to all parts of the world by now.  The potential for exponential growth in the threat from this virus could be just days or weeks away.

Far too many people are too young to have any knowledge of the 1855 Third Plague Pandemic that originated in China.  This outbreak quickly spread to India and Hong Kong and claimed 15 million victims.  It lasted until the 1960s when active cases of the Plague dropped below a couple hundred.

If we consider the broader scope of this issue, we have to take into consideration the results it may have on the broader global economy, commodities and consumer activity as skilled traders.

The world is much bigger than it was in 1855.  We have more technology, more capability and faster response capabilities related to this potential pandemic.  Yet, we also have a much greater heightened inter-connected global economy, currency, and commodity markets.  What happened in China can, and may, result in some crisis events throughout the planet.  It is not the same world as it was in 1855. (Source: history.com)

It is far too early to speculate on any future economic outcomes related to this potential outbreak, but it is fairly certain that China, most of Asia, India and potentially Africa could see extensive economic damage related to a contraction in consumer and industrial economic demand as a consequence of this outbreak.  Once the Chinese New Year ends, in about 10 to 15+ days, people will return back to their home cities and we’ll begin to understand the total scope of this problem.  If the problem continues to be isolated in China, Asia and within that general region, then we may see economic consequences isolated to these regions.  If not, then we could see a much bigger and broader global economic consequence setting up.

The 1855 Plague Pandemic lasted for nearly 100 years and wiped out 1.25% of the total global population.  This was at a time when air travel was very limited and global economics was a much smaller component of the total global economy.  Everything is somewhat isolated at that time. In today’s world, a similar type of event could wipe our 1% to 5% of the total global population before we have any means to attempt to control it.

Bill Gates believes this outbreak could kill more than 30 million people within 6 months (Source: businessinsider.com)

It is time to get real about this and prepare for how the global markets will interpret this potential outbreak.

We’ve been warning that the market was “Rallying To A Peak” recently and believe this outbreak has changed the minds of traders.  This could the catalyst that breaks the bullish trend for quite a while.  Skilled traders will be trying to get ahead of this rotation in the markets and attempt to deleverage risk.  As retail traders, we should be doing the same thing – deleveraging risk, buying metals, trimming open long positions and hedging into inverted ETFs.

Daily ES Chart

This Daily ES chart highlights a very real support level near 3050 that also aligns with the longer-term Moving Average.  A downside move like this would represent a -10 to -11% downside price reversion and take us back to December 2019 price levels.  It could happen very quickly.

Transportation Index Chart

This Transportation Index chart highlights a potential downside price reversion of -11% to -12% – targeting the 9,750 level.  We’ve recently authored an article about the weakness in the Transportation Index and how we believe it could be setting up for a downward price move.  If a breakdown move like this happens in TRAN, it would suggest a massive contraction in the global economy is taking place.

DOW JONES (YM) Daily Chart

This last YM chart highlights support near 28,000 which would be an immediate downside target if the Dow Jones Industrials revert lower.  And, again, this would put us back to December 2019 price levels.  If this 28,000 level is broken, then we start looking at levels closer to 26,000 (roughly -20%).

Concluding Thoughts:

Right now, consider this situation as you are a captain of a ship sailing into a storm.  You can either prepare for it and navigate through it to the best of your ability or ignore the warnings and hope for the best.  It is far too early to panic at this point, but a certain degree of “preparation” is certainly in order.

We’ll know more in about 7+ days as we learn how far and how wide this problem has actually extended.  In the meantime, watch your investments.  Protect your assets.  Prepare for the storm.  Best case, you can always reposition your capital for clearer skies in a few weeks.

As a technical analysis and trader since 1997 I have been through a few bull/bear market cycles, I have a good pulse on the market and timing key turning points for both short-term swing trading and long-term investment capital. The opportunities are massive/life-changing if handled properly.

Join my Wealth Building Newsletter if you want winning ETF swing trade alerts every month? Then ride my coattails as I make money while others will struggle and lose money as the markets correct and become more volatile.

Chris Vermeulen
TheTechnicalTraders.com

NOTICE: Our free research does not constitute a trade recommendation or solicitation for our readers to take any action regarding this research.  It is provided for educational purposes only.  Our research team produces these research articles to share information with our followers/readers in an effort to try to keep you well informed.  Visit our web site (www.thetechnicaltraders.com) to learn how to take advantage of our members-only research and trading signals.